259 related articles for article (PubMed ID: 32287312)
41. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
42. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos.
Lunavat TR; Cheng L; Kim DK; Bhadury J; Jang SC; Lässer C; Sharples RA; López MD; Nilsson J; Gho YS; Hill AF; Lötvall J
RNA Biol; 2015; 12(8):810-23. PubMed ID: 26176991
[TBL] [Abstract][Full Text] [Related]
43. Circulating or tissue microRNAs and extracellular vesicles as potential lung cancer biomarkers: a systematic review.
Song Y; Yu X; Zang Z; Zhao G
Int J Biol Markers; 2018 Jan; 33(1):3-9. PubMed ID: 29076520
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
Golabchi K; Soleimani-Jelodar R; Aghadoost N; Momeni F; Moridikia A; Nahand JS; Masoudifar A; Razmjoo H; Mirzaei H
J Cell Physiol; 2018 Apr; 233(4):3016-3023. PubMed ID: 28657205
[TBL] [Abstract][Full Text] [Related]
45. Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer.
Delcorte O; Craps J; Mahibullah S; Spourquet C; D'Auria L; Van Der Smissen P; Dessy C; Marbaix E; Mourad M; Pierreux CE
Endocr Relat Cancer; 2022 May; 29(7):389-401. PubMed ID: 35521768
[TBL] [Abstract][Full Text] [Related]
46. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
48. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
Yoshioka Y; Katsuda T; Ochiya T
Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
[TBL] [Abstract][Full Text] [Related]
49. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
50. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
51. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas.
Drees EEE; Pegtel DM
Trends Cancer; 2020 Nov; 6(11):910-923. PubMed ID: 32660885
[TBL] [Abstract][Full Text] [Related]
52. Multiplexed Detection and Quantitation of Extracellular Vesicle RNA Expression Using NanoString.
Shukla N; Yan IK; Patel T
Methods Mol Biol; 2018; 1740():177-185. PubMed ID: 29388144
[TBL] [Abstract][Full Text] [Related]
53. EVmiRNA: a database of miRNA profiling in extracellular vesicles.
Liu T; Zhang Q; Zhang J; Li C; Miao YR; Lei Q; Li Q; Guo AY
Nucleic Acids Res; 2019 Jan; 47(D1):D89-D93. PubMed ID: 30335161
[TBL] [Abstract][Full Text] [Related]
54. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
Akers JC; Ramakrishnan V; Kim R; Phillips S; Kaimal V; Mao Y; Hua W; Yang I; Fu CC; Nolan J; Nakano I; Yang Y; Beaulieu M; Carter BS; Chen CC
J Neurooncol; 2015 Jun; 123(2):205-16. PubMed ID: 25903655
[TBL] [Abstract][Full Text] [Related]
55. Acute Resistance Exercise Modifies Extracellular Vesicle miRNAs Targeting Anabolic Gene Pathways: A Prospective Cohort Study.
Conkright WR; Kargl CK; Hubal MJ; Tiede DR; Beckner ME; Sterczala AJ; Krajewski KT; Martin BJ; Flanagan SD; Greeves JP; O'Leary TJ; Wardle SL; Sahu A; Ambrosio F; Nindl BC
Med Sci Sports Exerc; 2024 Jul; 56(7):1225-1232. PubMed ID: 38377006
[TBL] [Abstract][Full Text] [Related]
56. The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells.
Ko SY; Lee W; Weigert M; Jonasch E; Lengyel E; Naora H
J Extracell Vesicles; 2023 Apr; 12(4):e12318. PubMed ID: 36973758
[TBL] [Abstract][Full Text] [Related]
57. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
[TBL] [Abstract][Full Text] [Related]
58. Comparative and functional analysis of plasma membrane-derived extracellular vesicles from obese vs. nonobese women.
Santamaria-Martos F; Benitez ID; Latorre J; Lluch A; Moreno-Navarrete JM; Sabater M; Ricart W; Sanchez de la Torre M; Mora S; Fernández-Real JM; Ortega FJ
Clin Nutr; 2020 Apr; 39(4):1067-1076. PubMed ID: 31036413
[TBL] [Abstract][Full Text] [Related]
59. Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells.
Eirin A; Zhu XY; Puranik AS; Woollard JR; Tang H; Dasari S; Lerman A; van Wijnen AJ; Lerman LO
PLoS One; 2017; 12(3):e0174303. PubMed ID: 28333993
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
